Smith & Nephew plc (ADR) (SN:SNN)

Business Focus: Medical Devices & Implants

Get the company report for the most recent outlook updated daily

Apr 18, 2024 07:00 am ET

Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention

Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group published in the International Wound Journal,1...

Apr 04, 2024 11:13 am ET

Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE) for its PICO Single Use Negative Pressure Wound...

Apr 01, 2024 08:00 am ET

Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce the launch of its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System in the US as a patient-centric option for treating chronic wounds....

Mar 25, 2024 08:00 am ET

Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been named the Preferred Sports Medicine Technology Partner of UFC – the world’s premier mixed martial arts organization and one of the foremost global...

Feb 28, 2024 08:00 am ET

Smith+Nephew and U.S. Army Institute of Surgical Research to engage in Master Cooperative Research and Development Agreement

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announced they have entered into a Master Cooperative Research and Development Agreement (CRADA) with the U.S. Army Institute of Surgical Research (USAISR). This marks the...

Feb 13, 2024 08:00 am ET

Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces full commercial availability of its AETOS Shoulder System in the US, along with 510(k) clearance for its use with ATLASPLAN◊ 3D Planning Software and Patient...

Feb 12, 2024 03:00 pm ET

Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting

Smith+Nephew (LSE: SN, NYSE:SNN), the global medical technology company, announces it will provide a glimpse into the future at AAOS 2024. With a first opportunity to see a forthcoming new feature* for its CORI◊ Surgical System, this exclusive...

Feb 12, 2024 08:00 am ET

Smith+Nephew unveils expanded Sports Medicine portfolio to enable biological healing at AAOS 2024 Annual Meeting

12 February 2024 Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the premiere of its newly acquired CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant alongside the REGENETEN◊ Bioinductive Implant at the AAOS Annual...

Jan 11, 2024 07:00 am ET

New study confirms Smith+Nephew’s REGENETEN™ Bioinductive Implant reduces full-thickness rotator cuff re-tear rates¹ by 68%

First published randomized controlled trial for market-leading implant demonstrates impressive outcomes for rotator cuff tears Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces...

Oct 11, 2023 02:00 am ET

Smith+Nephew opens new state-of-the-art surgical innovation and training centre in the heart of Munich

LONDON, Oct. 11, 2023 /CNW/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company specialising in orthopaedics, advanced wound management and sports medicine, is pleased to announce the opening of the purpose-built Smith+Nephew Academy Munich, a new centre for surgical innovation and training.

Oct 11, 2023 02:00 am ET

Smith+Nephew opens new state-of-the-art surgical innovation and training centre in the heart of Munich

LONDON, Oct. 11, 2023 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company specialising in orthopaedics, advanced wound management and sports medicine, is pleased to announce the opening of the purpose-built Smith+Nephew Academy Munich, a new centre for surgical innovation and training.

Jun 12, 2023 10:00 am ET

Smith+Nephew announces 510(k) clearance of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement

LONDON, June 12, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its AETOS Shoulder System.

May 16, 2023 08:00 am ET

Smith+Nephew helps personalize robotically-enabled surgery with AI-powered planning software and data visualization platform

LONDON, May 16, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today introduces two key products that close the feedback loop for its robotics and digital surgery portfolio – Personalized Planning powered by AI and RI.INSIGHTS Data Visualization Platform.

May 02, 2023 08:00 am ET

Smith+Nephew receives Innovative Technology contract from Vizient for PICO™ Single Use Negative Pressure Wound Therapy Systems

Contract awarded for products that bring improvement to healthcare industry

Apr 24, 2023 08:00 am ET

Smith+Nephew introduces first of its kind handheld digital tensioning device for robotically-enabled total knee arthroplasty

LONDON, April 24, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today introduced its new CORI™ Digital Tensioner - a purpose built device that lets surgeons measure the ligament tension in a knee prior to cutting bone.1 By enabling a surgeon to quantify joint laxity in the native knee and achieve an optimal ligament tensioning force, the CORI Digital Tensioner helps to reduce variability when balancing the knee in surgery.1-4 This helps make surgical planning more objective versus other commercially available alternatives.1,3

Mar 23, 2023 08:00 am ET

New evidence demonstrates Smith+Nephew's COBLATION™ Technology can accelerate patient recovery with fewer complications compared with total tonsillectomy techniques

LONDON, March 23, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces results from new scientific research that shows its COBLATION Intracapsular Tonsillectomy (CIT) technique can lead to improved post-operative outcomes in patients versus total tonsillectomy techniques. The research was recently published online by OTO Open: The Open Access Journal of the American Academy of Otolaryngology-Head and Neck Surgery Foundation.

Mar 08, 2023 07:00 am ET

Smith+Nephew to highlight procedural innovations in Sports Medicine during AAOS 2023 Annual Meeting

LONDON, March 8, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN) (NYSE:SNN), the global medical technology company, today announces it will showcase its latest Sports Medicine procedural innovations for joint repair and arthroscopic enabling technologies during the American Academy of Orthopaedic Surgeons 2023 Annual Meeting being held in Las Vegas, NV. These include:

Jan 30, 2023 07:00 am ET

Smith+Nephew receives Innovative Technology designation from Vizient for LEAF™ Patient Monitoring System

Designation recognizes Vizient-contracted products that bring improvements to healthcare industry

Nov 01, 2022 08:00 am ET

Smith+Nephew expands procedural innovation with introduction of JOURNEY™ II ROX™ Total Knee Solution

LONDON, Nov. 1, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of its JOURNEY II ROX Total Knee Solution – a reverse hybrid construct for total knee arthroplasty. This new procedural product solution aims to provide surgeons with the clinical advantage of an advanced bearing material and anatomic design combined with the efficiency1 and potential long-term tibia fixation of a cementless knee.

Sep 26, 2022 08:00 am ET

Smith+Nephew first to market with revision knee indication on robotics platform

LONDON , Sept. 26, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the first cases for revision knee replacement utilizing its CORI◊ Surgical System. Dr. Thorsten Seyler of Duke University performed the first cases on August 17, 2022, combining Smith+Nephew's handheld robotics technology with its LEGION◊ Revision Knee System. Smith+Nephew is the first orthopaedics company to receive FDA 510(k) clearance for a revision indication using a robotics-assisted platform.

Sep 21, 2022 08:00 am ET

Smith+Nephew Academy expands global access to professional medical education through virtual reality and other advanced simulation technologies

LONDON , Sept. 21, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it is expanding the reach of its medical education curriculum through a suite of advanced simulation technologies. Healthcare professionals can now conveniently access core orthopaedic, robotics and sports medicine procedural skills-training using virtual and augmented reality, haptics, and 3D interactive gaming at every Smith+Nephew Academy centre of excellence around the world.

Sep 14, 2022 08:00 am ET

New randomized controlled trial shows that addition of Smith+Nephew's REGENETEN™ Bioinductive Implant delivers 86% reduction in rotator cuff re-tear rates at 12 months

LONDON, Sept. 14, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE: SNN), the global medical technology company, today announces promising new data furthering a number of published studies supporting the use of its REGENETEN Bioinductive Implant in rotator cuff repair. Interim analysis from a randomized controlled trial (RCT) shows a significant reduction in the re-tear rate of full-thickness rotator cuff repairs when using the REGENETEN Bioinductive Implant.

Aug 04, 2022 08:00 am ET

Smith+Nephew's OXINIUM™ Technology Tour of Change touches down at the Pro Football Hall of Fame during enshrinement weekend

LONDON, Aug. 4, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN) (NYSE: SNN), the global medical technology company, today announces that the OXINIUM Technology Tour of Change mobile exhibit will make a stop at the Pro Football Hall of Fame during its enshrinement weekend in Canton, Ohio from August 4-6. As the official joint replacement technology of the Pro Football Hall of Fame, Smith+Nephew is committed to educating retired players, their families, and the community about the differences in material, design and technology to consider when selecting a hip or knee replacement. Smith+Nephew is p

Jul 13, 2022 08:00 am ET

Smith+Nephew to showcase latest innovations for sports medicine joint repair at 2022 AOSSM Annual Meeting

LONDON, July 13, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN) (NYSE: SNN), the global medical technology company, today announces a robust line-up featuring several of its advanced joint repair solutions and a wide array of educational activities during the 2022 American Orthopaedic Society for Sport Medicine (AOSSM) Annual Meeting being held in Colorado Springs July 13-17. These include:

Jul 12, 2022 03:00 am ET

Smith+Nephew launches Clinical Support App to help reduce practice variation in wound care

LONDON, July 12, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the WOUND COMPASS™ Clinical Support App.

Jun 30, 2022 08:00 am ET

Smith+Nephew announces first robotic-assisted surgery using its LEGION™ CONCELOC™ Cementless Total Knee System

LONDON, June 30, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN), (NYSE: SNN), the global medical technology company, today announces the first robotic-assisted surgery using its LEGION CONCELOC Cementless Total Knee System was performed by Dr. Cyna Khalily, an orthopaedic surgeon specializing in adult reconstructive surgery of the hip and knee in Louisville, KY.

Jun 14, 2022 03:00 am ET

SMITH+NEPHEW SHARES NEW RESEARCH THAT ESTIMATES 3.5 BILLION HOURS OF NURSE TIME COULD BE RELEASED BY 2030 THROUGH SHARED WOUND CARE AND USE OF LONG-WEAR ADVANCED FOAM DRESSINGS

LONDON, June 14, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces the publication of a new peer-reviewed article in Wounds International. The article proposes that an estimated 3.5 billion hours of nursing time could be released globally by 2030 if shared care approaches between nurses and patients are adopted in chronic wound care alongside long-wear advanced foam dressings1.

Jun 08, 2022 08:00 am ET

Smith+Nephew announces first total hip replacement cases on its CORI™ Surgical System using RI.HIP MODELER and RI.HIP NAVIGATION

LONDON, June 8, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces that the first total hip arthroplasty (THA) procedure using RI.HIP MODELER, a new preoperative spinopelvic assessment tool, was performed by Dr. Rhett Hallows at Duke Regional Hospital. Separately, Dr. Thorsten Seyler performed the first-ever RI.HIP NAVIGATION procedure on the CORI Surgical System at Duke University in April.

Mar 31, 2022 08:00 am ET

Smith+Nephew announces new study showing GRAFIX™ Membrane cut the rate of diabetic foot ulcer recurrence in half compared to leading competitors

LONDON, March 31, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces the publication of a peer-reviewed study in the Advances in Wound Care Journal reporting outcomes for Medicare patients with a diabetic foot ulcer (DFU) that shows GRAFIX Cryopreserved Placental Membrane cut DFU recurrence rates in half compared to leading cellular and tissue-based product (CTP) competitors.1 (Link to publication).

Mar 22, 2022 08:00 am ET

Smith+Nephew to showcase latest Orthopaedic advancements in Cementless Knees, Total Hip Arthroplasty and Robotics at AAOS 2022 Annual Meeting

LONDON , March 22, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces it will it showcase its latest innovations for Orthopaedic Reconstruction and Robotics during the American Academy of Orthopaedic Surgeons 2022 Annual Meeting being held in Chicago, IL.

Mar 21, 2022 08:00 am ET

Smith+Nephew to feature Sports Medicine technology for joint repair and connected arthroscopic tower during AAOS 2022 Annual Meeting

LONDON, March 21, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces it will showcase its latest Sports Medicine innovations for joint repair and arthroscopic enabling technologies during the American Academy of Orthopaedic Surgeons 2022 Annual Meeting being held in Chicago, IL. The latest technologies include:

Mar 15, 2022 08:00 am ET

Smith+Nephew embarks on the OXINIUM™ Technology Tour of Change; a mobile learning exhibit to showcase the best performing bearing for total hip arthroplasty

LONDON, March 15, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces it has kicked-off the OXINIUM Technology Tour of Change mobile exhibit. OXINIUM (Oxidized Zirconium) Technology has established itself as the best performing bearing with the lowest risk of revision in total hip arthroplasty (THA) at 9-17 years1-4, with strong clinical performance in knees.5,6

Feb 10, 2022 07:00 am ET

Smith+Nephew announces first surgery for its JOURNEY™ II Medial Dished System for total knee arthroplasty

LONDON, Feb. 10, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the first completed surgery using its JOURNEY II Medial Dished (MD) System for total knee arthroplasty (TKA). The procedure was performed by Dr. Ran Schwarzkopf, Orthopedic Adult Hip and Knee Reconstruction at NYU Langone Health.

Jan 26, 2022 07:00 am ET

Smith+Nephew expands next-generation handheld robotic-assisted CORI™ Surgical System into total hip arthroplasty with RI.HIP NAVIGATION

LONDON, Jan. 26, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the expansion of indications on its CORI Surgical System - the industry's most advanced and efficient1,* handheld robotic solution in total knee arthroplasty1,*,† - to now include total hip arthroplasty (THA). Smith+Nephew's RI.HIP NAVIGATION - designed to help maximize accuracy and reproducibility by delivering patient-specific component alignment for THA – is now available for use on its CORI System.

Jan 19, 2022 01:00 am ET

Smith+Nephew acquires novel cementless partial knee system

LONDON, Jan. 19, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces the acquisition of Engage Surgical, owner of the only cementless unicompartmental (partial) knee system commercially available in the US.

Nov 24, 2021 07:00 am ET

Smith+Nephew launches Real Intelligence and CORI™ Surgical System; next generation handheld robotics platform in Canada

LONDON, Nov. 24, 2021 /CNW/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of its Real Intelligence brand of enabling technology solutions, as well as its next generation handheld robotics platform - the CORI Surgical System - in Canada.

Nov 23, 2021 02:00 am ET

Smith+Nephew launches 'turn-key' robotic-assisted surgical system; designed to quickly augment the orthopaedic team's skills set for greater accuracy(1-3) ¥ improved outcomes(4), and potentially an im

LONDON, Nov. 23, 2021 /PRNewswire/ -- Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, today announces the launch of CORI™ handheld robotics, an advanced system for both total and partial knee arthroplasties.

Nov 16, 2021 01:00 am ET

Smith+Nephew announces digital surgery and robotics innovation centre in Europe

LONDON, Nov. 16, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is proud to announce the creation of a purpose built digital surgery and robotics innovation centre, based in Munich, Germany.

Nov 09, 2021 06:00 pm ET

Smith+Nephew establishes its first Medical Education Centre for the Asia Pacific region in Singapore

State-of-the-art centre to focus on digital and robotic surgery

Nov 09, 2021 06:00 pm ET

Smith+Nephew establishes its first Medical Education Centre for the Asia Pacific region in Singapore

State-of-the-art centre to focus on digital and robotic surgery

Nov 02, 2021 08:00 am ET

Smith+Nephew introduces the LEGION™ CONCELOC™ Cementless Total Knee System with proprietary 3D printed Advanced Porous Titanium technology

LONDON, Nov. 2, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the introduction of its LEGION CONCELOC Cementless Total Knee System (TKS) and first completed surgical procedures.

Oct 26, 2021 08:00 am ET

Smith+Nephew's IODOSORB™ Range shown more than twice as likely to heal wounds than standard care

LONDON, Oct. 26, 2021 /PRNewswire/ -- Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, is pleased to announce the results of a systematic review and meta-analysis of comparative trials to determine the efficacy of its IODOSORB 0.9% Cadexomer Iodine Range* on chronic wounds versus standard care specific to the wound type.1

Sep 01, 2021 09:00 am ET

Smith+Nephew introduces pioneering new technologies for its JOURNEY™ II total knee arthroplasty portfolio

LONDON , Sept. 1, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the introduction of two significant new technologies to its total knee arthroplasty (TKA) portfolio - the JOURNEY II Medial Dished (MD) for TKA and SYNC Performance Instruments.

Sep 01, 2021 07:00 am ET

Smith+Nephew to expand Real Intelligence digital ecosystem and CORI™ Surgical System with total hip arthroplasty

LONDON, Sept. 1, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces significant enhancements to its Real Intelligence digital ecosystem and surgical robotics programs at the American Academy of Orthopaedic Surgeons (AAOS) 2021 Annual Meeting in San Diego. These include an exclusive preview of RI.HIP NAVIGATION software on the CORI Surgical System and the commercial availability of RI.INSIGHTS - a global data management platform designed to advance the standard of care for robotics-assisted joint replacement procedures.

Aug 31, 2021 09:00 am ET

Smith+Nephew launches new total ankle and total shoulder replacement technologies; showcases recently acquired Extremity Orthopaedics portfolio at AAOS

LONDON, Aug. 31, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces it will feature its recently expanded Extremities portfolio at the American Academy of Orthopaedic Surgeons 2021 Annual Meeting being held in San Diego, CA. The exciting new portfolio is the result of acquiring the Extremity Orthopaedics business of Integra LifeSciences earlier in 2021, and includes solutions for upper and lower extremity arthritis, and fracture management of the shoulder, elbow, wrist, hand, foot and ankle.

Aug 31, 2021 07:00 am ET

New data underscores material benefits of Smith+Nephew's OXINIUM™ DH Technology and OR3O™ Dual Mobility System for total hip arthroplasty versus Cobalt Chrome liners

LONDON, Aug. 31, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces it will showcase meaningful new material evidence for its OR3O Dual Mobility Hip System and OXINIUM DH Technology at the American Academy of Orthopedic Surgeons (AAOS) 2021 Annual Meeting in San Diego, CA. New data confirms a reduction in material loss and corrosion for OXINIUM DH (Diffusion Hardened) liners used with the OR3O System – an improvement on equivalent CoCr dual mobility liners within the test.1

Aug 30, 2021 09:00 am ET

Smith+Nephew to feature new Sports Medicine technology for joint repair and connected arthroscopic tower during AAOS 2021 Annual Meeting

LONDON, Aug. 30, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces it will showcase its latest Sports Medicine innovations for joint repair and arthroscopic enabling technologies during the American Academy of Orthopaedic Surgeons 2021 Annual Meeting being held in San Diego, CA. The latest technologies include:

Aug 30, 2021 07:00 am ET

Smith+Nephew's OXINIUM™ Technology recognized as the best performing bearing with lowest risk of revision in total hip arthroplasty

LONDON, Aug. 30, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces its proprietary OXINIUM (Oxidized Zirconium) Technology has established itself as the best performing bearing with the lowest risk of revision in total hip arthroplasty (THA)1-4, alongside similarly strong clinical performance in knees.5 These results are substantiated by four national and regional joint registries1-4 over the last 20 years with more than 2 million procedures4 to draw from.

Aug 17, 2021 08:00 am ET

Smith+Nephew expands its leading WEREWOLF™ Technology into total joint arthroplasty with launch of WEREWOLF FASTSEAL 6.0 Hemostasis Wand

LONDON, Aug. 17, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of WEREWOLF FASTSEAL 6.0 Hemostasis Wand, bringing its leading radio-frequency technology to orthopaedic reconstruction surgeons.

Jul 21, 2021 08:00 am ET

Study shows Smith+Nephew's REGENETEN™ Bioinductive Implant sets new standard of recovery for partial-thickness rotator cuff tears

LONDON, July 21, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces study results showing patients treated with just its REGENETEN Bioinductive Implant for partial-thickness rotator cuff tears (>3mm) experienced significantly improved shoulder function during early recovery compared to patients receiving a REGENETEN Implant plus traditional surgical repair, with equivalent efficacy at one year.1

Jul 07, 2021 08:00 am ET

Smith+Nephew launches the FAST-FIX™ FLEX Meniscal Repair System; extends all-inside repair possibilities with greater access across all zones of the meniscus*

LONDON, July 7, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of its FAST-FIX FLEX Meniscal Repair System, the only device to offer a surgeon-guided, bendable needle and shaft providing access to all zones of the meniscus. Improving access leads to a greater opportunity to repair the meniscus rather than remove it, resulting in long-term benefits to the patient.1-3, 13-15

Jan 27, 2021 03:00 am ET

Smith+Nephew's PICO™ Single Use Negative Pressure Wound Therapy System again shown to significantly reduce surgical site complications

LONDON, Jan. 27, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce a new publication showing that its PICO Single Use Negative Pressure Wound Therapy System (sNPWT) significantly reduced the odds of surgical site infections (SSIs) by 63%*, the odds of seroma by 77%†, and the odds of dehiscence by 30%‡. A significant benefit of these reduced odds was an almost 2-day reduction in length of stay§, suggesting potential for substantial efficiency gains across the healthcare system1.

Jan 12, 2021 07:00 am ET

Smith+Nephew partners with Movemedical to streamline inventory management and improve customer experience

LONDON, Jan. 12, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the successful introduction of its new field sales operations and inventory automation solution in the US in partnership with Movemedical. The new platform is designed to deliver a more simplified and efficient way for field sales reps to manage their daily inventory operations - ultimately helping them better serve their surgeon customers.

Dec 16, 2020 07:00 am ET

New data confirms Smith+Nephew technology as the best performing cementless construct for Total Hip Arthroplasty¹

LONDON, Dec. 16, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announced outstanding clinical results for its total hip arthroplasty (THA) portfolio in both the National Joint Registry for England, Wales and Northern Ireland (NJR) and the the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR). The data confirms Smith+Nephew's POLAR3™ Total Hip Solution - a proprietary combination of its POLARSTEM™ Cementless Stem, R3™ Acetabular System and OXINIUM™ Technology has the top performing cementless construct compon

Dec 08, 2020 07:00 am ET

Smith+Nephew announces RI.INSIGHTS - a global data analytics platform designed to advance the standard of care for robotics-assisted joint replacement procedures

LONDON, Dec. 8, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the introduction of RI.INSIGHTS, the first platform designed to enable orthopaedic surgeons to benchmark robotics surgical experiences with other users to optimize surgical planning and improve patient reported outcome measures (PROMs).

Nov 17, 2020 07:00 am ET

New data shows Smith+Nephew's NOVOSTITCH™ Meniscal Repair Systems achieve 82.6% success rate for difficult to repair¹ horizontal cleavage tears at two years follow-up

LONDON, Nov. 17, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce the conclusion of and successful two-year follow-up results from the STITCH Study for its novel NOVOSTITCH Meniscal Repair Systems. The two-year results make a compelling case for surgeons to consider repairing the meniscus versus removing it.

Nov 05, 2020 07:00 am ET

Smith+Nephew adds patient selection and care-pathway optimization tools to ARIA Digital Care Management Platform for ASCs

LONDON, Nov. 5, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the addition of ARIA SiteSelect and ARIA Optimized Recovery Pathways to its digital episode of care management platform, ARIA. These digital tools will help clinicians more consistently determine the appropriate surgical site of care for patients and standardize total joint care pathways with the objective of improving post-operative outcomes.

Oct 20, 2020 08:00 am ET

Smith+Nephew announces remote Physical Therapy (PT) functionality; expanding its ARIA Care Management Platform for ASCs

LONDON, Oct. 20, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, announces key tele-PT assets for its ARIA digital care management platform. ARIA Home PT, a remote physical therapy module will launch in early 2021, with a telehealth module planned for release shortly afterwards.

Sep 29, 2020 08:00 am ET

Integra LifeSciences Announces Definitive Agreement to Divest its Extremity Orthopedics Business to Smith+Nephew for $240 Million

Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has entered into a definitive agreement to sell its Extremity Orthopedics business to Smith+Nephew (LSE:SN, NYSE:SNN) for $240...

Jul 28, 2020 08:00 am ET

Smith+Nephew announces new RI.HIP NAVIGATION for Total Hip Arthroplasty

LONDON, July 28, 2020 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the launch of the RI.HIP NAVIGATION for total hip arthroplasty (THA). This new technology is designed to help maximize accuracy and reproducibility by delivering patient-specific component alignment – a critical factor for surgeons when assessing individual THA cases.

Jul 14, 2020 08:00 am ET

Smith+Nephew launches Real Intelligence and CORI™ Surgical System; next generation handheld robotics platform

LONDON, July 14, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of its Real Intelligence brand of enabling technology solutions, as well as its new generation handheld robotics platform - the CORI Surgical System.

Jun 18, 2020 08:00 am ET

Smith+Nephew announces new milestone with its OXINIUM™ Advanced Bearing System implants surpassing two million procedures

LONDON, June 18, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announced that over two million patients have been treated with implants made from OXINIUM Technology - a proprietary oxidized zirconium alloy used in hip and knee replacements.

Jun 16, 2020 03:00 am ET

Smith+Nephew's revolutionary REGENETEN™ Bioinductive Implant receives CE Mark

LONDON, June 16, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announced that its REGENETEN Bioinductive Implant has successfully received CE Mark certification allowing the implant to now be used and sold in key European markets. With more than 40,000 procedures completed since its US introduction, the REGENETEN implant has had a transformative impact on the way surgeons approach rotator cuff procedures.

Jun 11, 2020 08:00 am ET

Smith+Nephew launches INTELLIO™ Connected Tower Solution for improved operating room efficiency

LONDON, June 11, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of its new INTELLIO Connected Tower Solution which wirelessly connects and remotely controls multiple Sports Medicine systems from outside the sterile field.

Jun 03, 2020 03:00 am ET

New publication shows Smith+Nephew's OXINIUM™ (Oxidized Zirconium) on XLPE for total hip arthroplasty as best performing bearing beyond 10 years

LONDON, June 3, 2020 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announced the publication of new clinical evidence further validating the exceptional performance of its proprietary OXINIUM - Oxidized Zirconium - on XLPE (highly cross-linked polyethylene) for total hip arthroplasty (THA). The publication in The Journal of Bone and Joint Surgery Open Access analyses data from the National Joint Registry for England, Wales, Northern Ireland and the Isle of Man (NJR) and concludes that THA procedures using OXINIUM on XLPE were associated with

Jun 02, 2020 10:00 am ET

New study: Smith+Nephew PICO System cost effective vs traditional negative pressure in prevalent leg and foot ulcers

LONDON, June 2, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is excited to announce the publication of a health economic study in Wound Management and Prevention, which states that the use of PICO™ Single Use Negative Pressure Wound Therapy System (sNPWT) is estimated to be highly cost effective when compared with traditional NPWT (tNPWT), and may therefore provide opportunity to reduce the economic burden of venous leg ulcers (VLUs) and diabetic foot ulcers (DFUs).1

May 28, 2020 08:00 am ET

Smith+Nephew announces US launch of the revolutionary Tula® System for placement of ear tubes

LONDON, May 28, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce the market introduction and first commercial procedure of its Tula System – an in-office solution for placement of tympanostomy tubes (commonly known as ear tubes).

May 20, 2020 08:00 am ET

Smith+Nephew launches new JOURNEY™ II Unicompartmental Knee System

LONDON, May 20, 2020 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the launch of its new JOURNEY II Unicompartmental Knee (UK) System. Built on the heritage of one of the most clinically successful partial knees,1,2 and paired with proprietary OXINIUM™ Technology, JOURNEY II UK is designed to help patients rediscover their normal life.

May 14, 2020 08:00 am ET

Smith+Nephew reports promising early results for new OR3O™ Dual Mobility System for total hip arthroplasty

LONDON, May 14, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces its newly launched OR3O Dual Mobility System for total hip arthroplasty (THA) has received encouraging results from early surgeon experience. Utilizing proprietary OXINIUM™ DH Technology, the OR3O system offers the benefits of dual mobility - increased range of motion and "jump distance"1* – while also incorporating unique material advantages.

May 05, 2020 05:49 pm ET

Fiagon partners with Smith+Nephew to distribute its ENT surgical navigation portfolio in the Asia Pacific region

BERLIN, May 5, 2020 /PRNewswire/ -- Fiagon, a technology leader who develops and manufactures innovative surgical image guidance technologies, announced today a partnership with Smith+Nephew (NYSE: SNN, LSE: SN), a global medical technology business, to distribute its ENT surgical navigation portfolio in the Asia Pacific Asean region. This agreement covers China, the India subcontinent, Australia, New Zealand, and other ASEAN markets.

May 05, 2020 08:00 am ET

Smith+Nephew announces partnership with National Medical Billing Services, a leader in revenue cycle management

LONDON, May 5, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces a strategic partnership with St. Louis-based National Medical Billing Services (National Medical) to provide revenue cycle management (RCM) solutions to Ambulatory Surgery Centers (ASCs) across the US.

Jan 16, 2020 08:00 am ET

Clinical trial demonstrated superior wound closure rates with PICO◊ compared to traditional NPWT in lower extremity ulcers1

Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the publication of a new randomized controlled trial (RCT) which demonstrated that the use of PICO Single Use Negative Pressure Wound Therapy System (sNPWT) significantly reduced wound area, depth and volume compared to traditional negative pressure wound therapy (tNPWT) in patients with lower extremity ulcers.1*

Nov 08, 2019 07:00 am ET

Smith+Nephew launches industry-first OR3O™ Dual Mobility System utilising unique OXINIUM™ DH metal alloy for use in primary and revision hip arthroplasty

LONDON, Nov. 8, 2019 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of its OR3O Dual Mobility System for use in primary and revision hip arthroplasty. Compared with traditional solutions, dual mobility implants have a small diameter femoral head that locks into a larger polyethylene insert - increasing stability and offering improved range of motion.1

Nov 04, 2019 06:45 am ET

Accelerate Diagnostics Appoints Roland Diggelmann to its Board of Directors

TUCSON, Ariz., Nov. 4, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced that Roland Diggelmann has been appointed to its Board of Directors.

Oct 09, 2019 09:00 am ET

Smith+Nephew's NOVOSTITCH™ Meniscal Repair System shows 91.7% success rate in "STITCH" Study at one-year follow-up

LONDON, Oct. 9, 2019 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce results for its NOVOSTITCH Meniscal Repair System today at the International Cartilage Regeneration & Joint Preservation Society (ICRS), Vancouver, Canada highlighting one-year results of the STITCH Study.

Sep 26, 2019 09:00 am ET

Smith+Nephew introduces ground-breaking assurance program for TRIGEN™ INTERTAN™ Intertrochanteric Hip Fracture Nail

LONDON, Sept. 26, 2019 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announced the launch of its new INTERTAN Product Assurance (IPA) Program at the Orthopaedic Trauma Association Annual Meeting in Denver, CO. This first-of-its-kind program centers on the superior performance of the TRIGEN INTERTAN Intertrochanteric Hip Fracture Nail– a clinically proven product that yields better outcomes versus competitive single-screw devices.3

Sep 24, 2019 09:45 am ET

Smith+Nephew launches LENS 4K Surgical Imaging System

LONDON, Sept. 24, 2019 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of its LENS 4K Surgical Imaging System; a state-of-the-art visualization platform designed for end-to-end 4K imaging.

Sep 10, 2019 10:00 am ET

Smith+Nephew launches PICO™ 7Y in the US, a portable single use negative pressure wound therapy system to treat two wounds simultaneously

LONDON, Sept. 10, 2019 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, is pleased to announce the US launch of the new PICO 7Y Single Use Negative Pressure Wound Therapy System (sNPWT) with AIRLOCK™ Technology. This is the first PICO sNPWT pump to include an innovative integrated Y connector, enabling the utilization of two dressings concurrently from one pump, allowing for two wounds or incisions to be addressed simultaneously. PICO 7Y is appropriate for use on a variety of wound types such as closed surgical incisions, chronic and acute wounds.

Sep 05, 2019 08:00 am ET

Smith+Nephew launches new EVOS™ WRIST Plating System; an evolutionary treatment option for both simple and complex wrist fractures

LONDON, Sept. 5, 2019 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announced the launch of its EVOS WRIST Plating System at the American Society for Surgery of the Hand (ASSH) Annual Meeting in Las Vegas, Nevada.

Jul 11, 2019 07:00 am ET

Smith & Nephew meniscal knee repair technology delivers 0% re-operation rate and 100% meniscal healing at six months shows first ever study of horizontal cleavage tears

LONDON, July 11, 2019 /PRNewswire/ -- Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, today announces the results of the first ever prospective clinical trial to evaluate the effectiveness of repairing Horizontal Cleavage Tears (HCTs), one of the most common meniscal tears affecting approximately one-third of patients with this injury.1 The STITCH Study is examining the effectiveness of repair using Smith & Nephew's NOVOSTITCH™ Meniscal Repair System, available only in the US, which addresses complex meniscal tear patterns not adequately served by other r

May 22, 2019 10:00 am ET

Smith & Nephew's OXINIUM™ Technology for Hips could save the US Health System an estimated $296 Million in 2020

LONDON, May 22, 2019 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today presented new data at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Annual Meeting in New Orleans. This data, presented for the first time, compared 90-day episode of care outcomes for its proprietary OXINIUM™, Oxidized Zirconium alloy, bearing surface with all other non-OXINIUM bearing surfaces for total hip replacement surgery. Key takeaways included:

May 13, 2019 08:00 am ET

Smith & Nephew launches new FLOW 90™ Wand at ISAKOS joining its innovative collection of COBLATION™ technology and shoulder repair portfolios

LONDON, May 13, 2019 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the U.S. launch of the WEREWOLF™ FLOW 90 Wand with FLOW~IQ™ Technology. Designed for use in the shoulder but indicated for use on all soft tissue types, the 90-degree wand was developed to use with the WEREWOLF COBLATION System.

May 09, 2019 09:00 am ET

New NICE guidance recognises that Smith & Nephew’s PICO™ sNPWT provides better outcomes than standard dressings in patients at high risk of surgical site infections, at similar overall cost

Smith & Nephew (NYSE:SNN; LSE:SN), the global medical technology business, welcomes the launch of new medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE). In the guidance, NICE recommends that PICO Single Use Negative Pressure Wound Therapy System (sNPWT) should be considered as an option for closed surgical incisions in patients who are at high risk of surgical site infections (SSIs).1 Key patient risk factors include a high BMI, diabetes, renal insufficiency and smoking.2

Mar 14, 2019 05:27 pm ET

OSIRIS THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

Rigrodsky & Long, P.A.: Do you own shares of Osiris Therapeutics, Inc. (NASDAQ GM: OSIR)? Did you purchase any of your shares prior to March 12, 2019?Do you think the proposed buyout is fair?Do you want to discuss your rights? Rigrodsky & Long,...

Mar 13, 2019 03:00 pm ET

Smith & Nephew POLAR3™ Total Hip Solution demonstrates best-in-class results from world's largest registry

LONDON, March 13, 2019 /PRNewswire/ -- Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today at the American Academy of Orthopaedic Surgeons annual meeting in Las Vegas presented data around its POLAR3 Total Hip Solution. The POLARSTEM/R3 combination demonstrated the highest survivorship of any stem/cup combination regardless of fixation method at seven years1.

Mar 12, 2019 06:31 pm ET

Smith & Nephew Acquires Brainlab Orthopaedic Joint Reconstruction Business

LONDON, March 12, 2019 /PRNewswire/ -- Brainlab, the global pioneer of software-driven medical technology, and Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announce that Smith & Nephew has agreed to acquire the Brainlab orthopaedic joint reconstruction business.

Mar 12, 2019 06:30 pm ET

Smith & Nephew establishes multi-asset digital surgery and robotic ecosystem

LONDON, March 12, 2019 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announces product launches and investments that establish its multi-asset digital surgery and robotic ecosystem.

Mar 12, 2019 09:33 am ET

Smith & Nephew expands in high growth regenerative medicine market through acquisition of Osiris Therapeutics, Inc.

LONDON, March 12, 2019 /PRNewswire/ -- Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, announces that it has agreed to acquire Osiris Therapeutics, Inc. (NASDAQ: OSIR), a fast growing company delivering regenerative medicine products, including skin, bone graft and articular cartilage substitutes, for $19.00 per share in cash, representing a total equity value of approximately $660 million.

Mar 12, 2019 09:00 am ET

Osiris Therapeutics, Inc. Enters Agreement to be Acquired by Smith & Nephew plc

Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, today announced that it has entered into an agreement and plan of merger with...

Nov 16, 2018 09:46 am ET

Smith & Nephew Presents Excellent Results for JOURNEY™ II Total Knee at the 2018 American Association of Hip and Knee Surgeons

MEMPHIS, Tenn., Nov. 16, 2018 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, presented a number of compelling clinical outcomes around its flagship JOURNEY II BCS knee earlier this month at the American Association of Hip and Knee Surgeons (AAHKS). The announcement follows more than a dozen publications during the past year from various authors around the globe.1-14

Oct 17, 2018 08:00 am ET

Two new studies demonstrate INTERTAN™ Intertrochanteric Antegrade Nail improves patient outcomes and lowers healthcare costs when treating hip fractures

LONDON, Oct. 17, 2018 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announced at the Orthopaedic Trauma Association Annual Meeting in Orlando, FL USA two new studies showing positive clinical results and cost savings through using its INTERTAN Intertrochanteric Antegrade Nail.

Jul 25, 2018 09:02 am ET

JOURNEY™ II BCS Knee System demonstrates improved patient outcomes and lower healthcare costs

LONDON, July 25, 2018 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announced positive clinical results concerning its JOURNEY™ II Bi-Cruciate Stabilized (BCS) knees. These results suggest JOURNEY II BCS is associated with significant healthcare economic benefits in patients implanted with this device compared to other knee systems.

Mar 19, 2018 09:00 am ET

Smith & Nephew Supports AAFAO Courses with Donation of More Than $3M of Equipment to The Podiatry Institute

LONDON, March 19, 2018 /PRNewswire/ -- Smith & Nephew (NYSE:SNN; LSE:SN), the global medical technology business, today announces the donation of more than $3M of trauma plates and screws, external fixation implants and instruments to The Podiatry Institute (PI). This equipment will be used to support ongoing educational courses conducted at the PI through the American Academy of Foot and Ankle Osteosynthesis (AAFAO).

Mar 06, 2018 08:37 am ET

New Q-FIX™ CURVED, Q-FIX MINI and SUTUREFIX CURVED All-Suture Anchor Systems help surgeons access challenging pathology while improving the quality of shoulder and hip repairs

LONDON, March 6, 2018 /PRNewswire/ -- Smith & Nephew (NYSE:SNN, LSE: SN), the global medical technology business, is pleased to announce the launch of Q-FIX™ CURVED, Q-FIX MINI and SUTUREFIX CURVED All-Suture Anchor systems adding to its growing Sports Medicine portfolio. Designed for procedures where space is limited and the anatomy can be difficult to access, the new SUTUREFIX CURVED, Q-FIX CURVED and MINI delivery systems are designed to aid in optimal suture anchor placement during drilling and insertion.

Mar 06, 2018 08:00 am ET

Smith & Nephew announces full commercial release of JOURNEY™ II XR Total Knee Arthroplasty

LONDON, March 6, 2018 /PRNewswire/ -- Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the full commercial release of bi-cruciate retaining JOURNEY II XR total knee arthroplasty (TKA) in the United States and Japan.

Feb 15, 2018 08:00 am ET

Smith & Nephew: RCT demonstrates a 71% reduction in the onset of sacral pressure ulcers when adding ALLEVYN◊ LIFE to standard preventative protocol

Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, today announces the publication of a randomised controlled trial (RCT) demonstrating that the addition of ALLEVYN LIFE, Smith & Nephew’s leading multi-layer silicone adhesive foam dressing, to a standard care protocol significantly reduces the onset of pressure ulcers by 71% in elderly patients admitted to hospital for hip fracture1.

Jan 18, 2018 08:00 am ET

Smith & Nephew's Episode of Care Assurance Program (eCAP) reduces hospital readmission following total joint replacement surgery

LONDON, Jan. 18, 2018 /PRNewswire/ -- Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, today announces results showing a near 75% decrease in readmission rates for joint arthroplasties (TJA) conducted under its Episode of Care Assurance Program (eCAP).

Dec 11, 2017 05:18 am ET

Smith & Nephew Announce European Launch of Handheld Imaging Technology Heralding a New Era of Evidence-Based Decision Making in Wound Care

Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the European launch of MolecuLight i:XTM, the easy to use, handheld imaging device that instantly measures wound surface area and visualises the presence and distribution of potentially harmful bacteria in wounds.2,3

Nov 13, 2017 12:38 pm ET

International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on November 15th and 16th, 2017

NEW YORK, Nov. 13, 2017 /CNW/ -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on November 15th and 16th, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US.

Nov 13, 2017 12:38 pm ET

International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on November 15th and 16th, 2017

NEW YORK, Nov. 13, 2017 /PRNewswire/ -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on November 15th and 16th, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US.

Jun 29, 2017 09:00 am ET

Smith & Nephew expands NAVIO™ Robotics-assisted surgery system into Total Knee replacements

LONDON, June 29, 2017 /PRNewswire/ -- Smith & Nephew (NYSE:SNN; LSE:SN), the global medical technology business, today announces the launch of its NAVIO handheld robotics-assisted total knee arthroplasty (TKA) application. This expands the NAVIO platform to total knees, which comprise 80% of all knee replacement surgeries globally. The TKA application supports Smith & Nephew's JOURNEY II, LEGION Primary and GENESIS II Total Knee Systems.

Jun 06, 2017 09:00 am ET

Trice Medical Closes $19.3 Million Series C Financing To Address Increased Demand For Mi-Eye

KING OF PRUSSIA, Pa., June 6, 2017 /PRNewswire/ -- Trice Medical announced today that it closed a $19.3 million Series C financing and will use the proceeds to accelerate and expand the company's U.S. market penetration for mi-eye2™, R&D, sales, marketing and key international regulatory approvals. Smith & Nephew (LSE:SN, NYSE:SNN), a global medical technology business dedicated to helping healthcare professionals improve people's lives, has taken a minority stake joining a consortium of current investors including Safeguard Scientifics (NYSE:SFE), HealthQuest Capital, BioStar Ventur

May 04, 2017 09:00 am ET

Collagenase SANTYL® Ointment advances pressure ulcers through the healing process faster, new study suggests

LONDON, May 4, 2017 /PRNewswire/ -- Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, welcomes the publication of a new research paper showing how pressure ulcers, when treated with Collagenase SANTYL Ointment, achieve faster rates of granulation and epithelialization when compared against medicinal honey treatment. Granulation is the process in which new connective tissue and capillaries form around the edges of a wound while epithelialization is the regrowth of skin over an open wound.

Mar 16, 2017 09:37 am ET

International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on March 22nd and 23rd, 2017

NEW YORK, March 16, 2017 /CNW/ -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on March 22nd and 23rd, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US.

Mar 16, 2017 09:37 am ET

International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on March 22nd and 23rd, 2017

NEW YORK, March 16, 2017 /PRNewswire/ -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on March 22nd and 23rd, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US.

Mar 14, 2017 06:07 pm ET

Smith & Nephew previews NAVIO™ Robotics-assisted Total Knee Application at AAOS ahead of full market release in Q2 2017

LONDON, March 14, 2017 /PRNewswire/ -- Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, today announces the upcoming full market release of its NAVIO hand-held robotics-assisted total knee arthroplasty (TKA) system. Smith & Nephew will be hosting live hands-on demonstrations for surgeons at the 2017 Annual American Academy of Orthopaedic Surgeons meeting in San Diego, CA, March 15-17 (booth # 5133).

Feb 22, 2017 08:00 am ET

Smith & Nephew invests in and signs agreement to distribute disruptive Leaf Healthcare pressure injury technology

LONDON, Feb. 22, 2017 /PRNewswire/ -- Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, today announces it has taken a strategic investment and signed a distribution agreement with Leaf Healthcare, a developer of a unique wireless patient monitoring system for pressure ulcer/injury prevention.

Dec 01, 2016 03:36 pm ET

OrthoSpace Completes Equity Financing Round

CAESAREA, Israel, Dec. 1, 2016 /PRNewswire/ -- OrthoSpace, Ltd. (http://orthospace.co.il/), a global innovative shoulder implant company, today announces that it has closed on a $7 million equity financing round. The funds will be used to support the ongoing US Investigational Device Exemption (IDE) FDA Study, build out the Company's commercial activities in Europe, South America and Asia and provide working capital. Existing investors, HealthpointCapital LLC, Smith & Nephew and TriVentures participated in this round, alongside a new investor, Johnson & Johnson Innovation - JJDC, I

Nov 22, 2016 04:00 am ET

New WHO guidelines recommend the use of NPWT to help reduce the risk of Surgical Site Infection

LONDON, Nov. 22, 2016 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, welcomes the publication of new global guidelines from World Health Organisation (WHO) outlining strategies to reduce rates of surgical site infection (SSI).1

Nov 10, 2016 08:00 am ET

International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on November 16th and 17th, 2016

NEW YORK, Nov. 10, 2016 /CNW/ -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on November 16th and 17th, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US.

Nov 10, 2016 08:00 am ET

International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on November 16th and 17th, 2016

NEW YORK, Nov. 10, 2016 /PRNewswire/ -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on November 16th and 17th, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US.

Nov 08, 2016 02:29 pm ET

Enabling Improved Patient Outcomes with Smith & Nephew's Pioneering Episode of Care Assurance Program (eCAP)

LONDON, Nov. 8, 2016 /PRNewswire/ -- Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, announces that the U.S. health and wellness organization, Provider PPI LLC, has adopted its Episode of Care Assurance Program (eCAP), an innovation designed to mitigate risk associated with readmissions in value-based healthcare reimbursement models. Provider PPI LLC is a subsidiary of Highmark Health that provides group purchasing benefits to the hospitals of Allegheny Health Network and 60 additional healthcare providers in the western Pennsylvania region.

Aug 22, 2016 07:55 am ET

ACell®, Inc. Names Brad Adams Vice President of Sales

COLUMBIA, Md., Aug. 22, 2016 /PRNewswire/ -- ACell, Inc. today announced that it has named Brad Adams Vice President of Sales. He will be responsible for directing the strategy and execution of both field sales and national accounts.

Jul 28, 2016 09:00 am ET

Smith & Nephew's NAVIO™ Surgical System achieves robotics-assisted milestone for total knee replacement surgery

LONDON, July 28, 2016 /PRNewswire/ -- Smith & Nephew (NYSE:SNN; LSE:SN), the global medical technology business, today announces the first surgical case of its robotics-assisted total knee replacement procedure. The new approach, which recently received 510(k) clearance from the US Food and Drug Administration, uses the NAVIO Surgical System to implant the JOURNEY™ II BCS and CR total knee systems.

Jun 06, 2016 10:00 am ET

International companies to host live webcasts at Deutsche Bank's June 9th and 10th Depositary Receipts Virtual Investor Conference

NEW YORK, June 6, 2016 /CNW/ -- Deutsche Bank today announced the lineup for its June 9th and 10th Depositary Receipts Virtual Investor Conference ("dbVIC"), featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US.

Jun 06, 2016 10:00 am ET

International companies to host live webcasts at Deutsche Bank's June 9th and 10th Depositary Receipts Virtual Investor Conference

NEW YORK, June 6, 2016 /PRNewswire/ -- Deutsche Bank today announced the lineup for its June 9th and 10th Depositary Receipts Virtual Investor Conference ("dbVIC"), featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US.

Apr 12, 2016 09:00 am ET

Smith & Nephew awarded Skin Integrity: Prevention, Healing and Support category agreement with Premier, Inc.

LONDON, April 12, 2016 /PRNewswire/ -- Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announced that it has been awarded a group purchasing agreement for the Skin Integrity: Prevention, Healing and Support category with Premier, Inc. Effective April 1, 2016, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Smith & Nephew's Advanced Wound Care products, including the ALLEVYN™ family of hydrocellular foam dressings, SECURA™ skin care system and ACTICOAT™ silver-c

Apr 07, 2016 09:00 am ET

Smith & Nephew Continues Support of Wound Care Nurses

LONDON, April 7, 2016 /PRNewswire/ -- Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, today announces a third annual educational grant to the Wound, Ostomy and Continence Nurses Society™ (WOCN®). Through the restricted educational grant, Smith & Nephew is supporting Wound, Ostomy and Continence (WOC) Nurse Week, April 10-16, honoring the care WOC nurses provide to millions of patients in need of care.

Mar 09, 2016 08:00 am ET

New "see-and-treat" TRUCLEAR™ hysteroscope improves options for office hysteroscopy

LONDON, March 9, 2016 /PRNewswire/ -- Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, today announced the launch of the TRUCLEAR 5C Hysteroscope Set for the combined diagnosis and removal of abnormalities within the uterine cavity. The ability to identify and remove intrauterine pathologies using a single scope is known as "see-and-treat" by surgeons and reduces the need for patients to schedule multiple visits.

Mar 01, 2016 08:00 am ET

Smith & Nephew unveils its first 3D-printed titanium hip implant 1 March 2016

LONDON, March 1, 2016 /PRNewswire/ -- Smith & Nephew (NYSE:SNN; LSE:SN), the global medical technology business, is showcasing the new REDAPT™ Revision Acetabular Fully Porous Cup with CONCELOC™ Technology at this week's American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting in Orlando.

Error message

Ad blocking detected

Smith & Nephew plc (ADR) (SN:SNN)

Business Focus: Medical Devices & Implants